Flammulina velutipes protein extract and applications thereof for resisting tumor
A protein extract, Flammulina velutipes technology, applied in anti-tumor drugs, peptide/protein components, applications, etc., can solve problems such as blanks
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0032] Embodiment 1, the preparation of Flammulina velutipes protein extract
[0033] 1. Prepare the fruiting bodies of Flammulina velutipes
[0034] Inoculate Flammulina velutipes hybrid 19CFCC89540 slant bacteria into the first-level medium for activation, culture at a constant temperature at 25°C, and inoculate it into the second-level medium after the mycelium is full of the test tube, in a constant-temperature culture room at 25°C Cultivate until the hyphae are overgrown, inoculate the secondary species into the cultivation bag with the cultivation medium for germination at 25°C, scratch the fungus after the strain is full of the cultivation bag, and move it into the greenhouse. The fruiting conditions are maintained The humidity is above 90%, and the temperature is 10-15°C. Collect the fruiting body of the first tide, and obtain the fruiting body of Flammulina velutipes hybrid 19CFCC89540.
[0035] Wherein, the culture medium used in this experiment is as follows:
[0...
Embodiment 2
[0043] Embodiment 2, Flammulina velutipes protein extract inhibits tumor cell proliferation experiment
[0044] 1.1 Tested cell lines
[0045] Human liver cancer HepG2 cells (purchased from ATCC, USA), human breast cancer MCF-7 cells (purchased from ATCC, USA) and human lung adenocarcinoma A-549 cells (purchased from ATCC, USA).
[0046] 1.2 Experimental method
[0047] 1.2.1 Cell lines and cell culture
[0048] Human liver cancer HepG2 cells, human breast cancer MCF-7 cells and human lung adenocarcinoma A-549 cells were activated and passaged according to conventional culture methods. Among them, the subculture and activation medium of human liver cancer HepG2 cells is DMEM-high glucose + 1% double antibody + 10% FBS (in DMEM-high glucose (Hyclone, SH30022.01B) a mixture of penicillin and streptomycin (penicillin 10000U / mL, streptomycin 10000μg / mL) and fetal bovine serum (FBS, Hyclone, SV30087.02), so that the final volume percentage of the former two is 1%, and the volume...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com